Probuphine is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Titan Pharmaceuticals, Inc.. The primary component is Buprenorphine Hydrochloride.
Product ID | 52440-100_059a263d-9a75-4c1e-a0c6-73867047e0c8 |
NDC | 52440-100 |
Product Type | Human Prescription Drug |
Proprietary Name | Probuphine |
Generic Name | Buprenorphine Hydrochloride |
Dosage Form | Implant |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2016-06-09 |
Marketing Category | NDA / NDA |
Application Number | NDA204442 |
Labeler Name | Titan Pharmaceuticals, Inc. |
Substance Name | BUPRENORPHINE HYDROCHLORIDE |
Active Ingredient Strength | 80 mg/1 |
Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC] |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-06-09 |
Marketing End Date | 2021-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204442 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-06-09 |
Ingredient | Strength |
---|---|
BUPRENORPHINE HYDROCHLORIDE | 80 mg/1 |
SPL SET ID: | f635d975-6bb4-4233-953b-d5724e993839 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
52440-100 | Probuphine | buprenorphine hydrochloride |
58284-100 | Probuphine | Probuphine |
55700-867 | BELBUCA | buprenorphine hydrochloride |
12496-0757 | Buprenex | buprenorphine hydrochloride |
50090-2924 | Buprenorphine | Buprenorphine Hydrochloride |
0143-9246 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
0409-2012 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
0517-0725 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
21695-515 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
35356-556 | buprenorphine hydrochloride | buprenorphine hydrochloride |
42023-179 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
50090-1571 | buprenorphine hydrochloride | buprenorphine hydrochloride |
50383-924 | buprenorphine hydrochloride | buprenorphine hydrochloride |
50383-930 | buprenorphine hydrochloride | buprenorphine hydrochloride |
53217-246 | buprenorphine hydrochloride | buprenorphine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PROBUPHINE 86356901 5171923 Live/Registered |
Titan Pharmaceuticals, Inc. 2014-08-04 |
PROBUPHINE 85867659 5166633 Live/Registered |
Titan Pharmaceuticals, Inc. 2013-03-05 |
PROBUPHINE 85110551 4102980 Live/Registered |
Titan Pharmaceuticals, Inc. 2010-08-18 |
PROBUPHINE 76281064 2800862 Dead/Cancelled |
Titan Pharmaceuticals, Inc. 2001-07-06 |